Serum level of LOX-1 ligand containing ApoB is associated with increased carotid intima-media thickness in Japanese community-dwelling men, especially those with hypercholesterolemiaLOX-1 ligand and IMT in Japanese

Published:November 05, 2015DOI:


      • We recruited 992 community-dwelling Japanese men with a mean age of 63.8 ± 10.0 years.
      • The serum levels of LAB and carotid intima-media thickness were measured.
      • LAB was associated with carotid IMT after adjustment for traditional risk factors.
      • The association was diminished by further adjustment for total cholesterol (TC).
        LAB was associated with IMT in high TC participants after further adjustment for TC.


      The serum level of LOX-1 ligand containing ApoB (LAB) may reflect atherogenicity better than usual lipid parameters; however, the relationship between LAB and carotid intima-media thickness (IMT) was not clear even in Asian populations.


      A total of 992 community-dwelling Japanese men, aged 40 to 79 years, were enrolled in the present study. Serum LAB levels were measured by enzyme-linked immunosorbent assays (ELISAs) with recombinant LOX-1 and monoclonal anti-apolipoprotein B antibody.


      Serum LAB levels (median [interquartile range], μg cs/L) were 5341 μg cs/L (4093–7125). The mean average IMT of the common carotid artery was highest in the fourth LAB quartile (842 μm) compared with the first quartile (797 μm) after adjustment for age, high-density lipoprotein cholesterol, triglyceride, body mass index, hypertension, diabetes, high sensitivity C-reactive protein, smoking, and alcohol drinking. However, this statistically significant difference was lost after further adjustment for total cholesterol (TC). After stratification using the combination of median LAB and hypercholesterolemia (serum TC ≥ 6.21 mmol/L and/or lipid-lowering medication), the adjusted mean average IMT (standard error) in the high LAB/hypercholesterolemia group was 886 μm (12.7), 856 μm (16.7) in the low LAB/hypercholesterolemia group, and 833 μm (8.4) in the low LAB/normal cholesterol group (P = .004). After further adjustment for TC, mean average IMT in the high LAB group was significantly higher than that measured in the low LAB group in hypercholesterolemic participants not taking lipid-lowering medication.


      Serum LAB was associated with an increased carotid IMT in Japanese men, especially those with hypercholesterolemia.


      To read this article in full you will need to make a payment


      Subscribe to Journal of Clinical Lipidology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), ESC Committee for Practice Guidelines 2008-2010 and 2010-2012 Committees
        ESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
        Atherosclerosis. 2011; 217: S1-44
        • Goff Jr., D.C.
        • Lloyd-Jones D.M.
        • Bennett G.
        • et al.
        • American College of Cardiology/American Heart Association Task Force on Practice Guidelines
        2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
        J Am Coll Cardiol. 2014; 63: 2935-2959
        • Teramoto T.
        • Sasaki J.
        • Ishibashi S.
        • et al.
        Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan—2012 version.
        J Atheroscler Thromb. 2013; 20: 517-523
        • Sugiyama D.
        • Okamura T.
        • Watanabe M.
        • et al.
        Risk of hypercholesterolemia for cardiovascular disease and the population attributable fraction in a 24-year Japanese cohort study.
        J Atheroscler Thromb. 2015; 22: 95-107
        • Mudd J.O.
        • Borlaug B.A.
        • Johnston P.V.
        • et al.
        Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease.
        J Am Coll Cardiol. 2007; 50: 1735-1741
        • Sawamura T.
        • Kume N.
        • Aoyama T.
        • et al.
        An endothelial receptor for oxidized low-density lipoprotein.
        Nature. 1997; 386: 73-77
        • Apostolov E.O.
        • Shah S.V.
        • Ray D.
        • Basnakian A.G.
        Scavenger receptors of endothelial cells mediate the uptake and cellular proatherogenic effects of carbamylated LDL.
        Arterioscler Thromb Vasc Biol. 2009; 29: 1622-1630
        • Sawamura T.
        • Kakino A.
        • Fujita Y.
        LOX-1: a multiligand receptor at the crossroads of response to danger signals.
        Curr Opin Lipidol. 2012; 23: 439-459
        • Sato Y.
        • Nishimichi N.
        • Nakano A.
        • et al.
        Determination of LOX-1 ligand activity in mouse plasma with a chicken monoclonal antibody for ApoB.
        Atherosclerosis. 2008; 200: 303-309
        • Yamazaki K.
        • Bujo H.
        • Taira K.
        • et al.
        Increased circulating malondialdehyde-modified LDL in the patients with familial combined hyperlipidemia and its relation with the hepatic lipase activity.
        Atherosclerosis. 2004; 172: 181-187
        • Itabe H.
        • Ueda M.
        Measurement of plasma oxidized low-density lipoprotein and its clinical implications.
        J Atheroscler Thromb. 2007; 14: 1-11
        • Okamura T.
        • Sekikawa A.
        • Sawamura T.
        • et al.
        LOX-1 ligands containing apolipoprotein B and carotid intima-media thickness in middle-aged community-dwelling US Caucasian and Japanese men.
        Atherosclerosis. 2013; 229: 240-245
        • Kadota A.
        • Miura K.
        • Okamura T.
        • et al.
        Carotid intima-media thickness and plaque in apparently healthy Japanese individuals with an estimated 10-year absolute risk of CAD death according to the Japan Atherosclerosis Society (JAS) guidelines 2012: the Shiga Epidemiological Study of Subclinical Atherosclerosis (SESSA).
        J Atheroscler Thromb. 2013; 20: 755-766
        • Hisamatsu T.
        • Fujiyoshi A.
        • Miura K.
        • et al.
        Lipoprotein particle profiles compared with standard lipids in association with coronary artery calcification in the general Japanese population.
        Atherosclerosis. 2014; 236: 237-243
        • Nakamura M.
        • Sato S.
        • Shimamoto T.
        Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL-cholesterol by the US Cholesterol Reference Method Laboratory Network.
        J Atheroscler Thromb. 2003; 10: 145-153
        • Iwamoto S.
        • Fujita Y.
        • Kakino A.
        • et al.
        An alternative protein standard to measure activity of LOX-1 ligand containing apoB (LAB)—utilization of anti-LOX-1 single-chain antibody fused to apoB fragment.
        J Atheroscler Thromb. 2011; 18: 818-828
        • Sekikawa A.
        • Kadowaki T.
        • El-Saed A.
        • et al.
        Differential association of docosahexaenoic and eicosapentaenoic acids with carotid intima-media thickness.
        Stroke. 2011; 42: 2538-2543
        • NIPPON DATA80 Research Group
        Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population.
        Circ J. 2006; 70: 1249-1255
        • Liu M.L.
        • Ylitalo K.
        • Salonen R.
        • Salonen J.T.
        • Taskinen M.R.
        Circulating oxidized low-density lipoprotein and its association with carotid intima-media thickness in asymptomatic members of familial combined hyperlipidemia families.
        Arterioscler Thromb Vasc Biol. 2004; 24: 1492-1497
        • Hinagata J.
        • Kakutani M.
        • Fujii T.
        • et al.
        Oxidized LDL receptor LOX-1 is involved in neointimal hyperplasia after balloon arterial injury in a rat model.
        Cardiovasc Res. 2006; 69: 263-271
        • Honjo M.
        • Nakamura K.
        • Yamashiro K.
        • et al.
        Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation.
        Proc Natl Acad Sci U S A. 2003; 100: 1274-1279
        • Li L.
        • Sawamura T.
        • Renier G.
        Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation.
        Circ Res. 2004; 94: 892-901
        • Uchida K.
        • Suehiro A.
        • Nakanishi M.
        • Sawamura T.
        • Wakabayashi I.
        Associations of atherosclerotic risk factors with oxidized low-density lipoprotein evaluated by LOX-1 ligand activity in healthy men.
        Clin Chim Acta. 2011; 412: 1643-1647
        • Uzui H.
        • Hayashi H.
        • Nakae I.
        • et al.
        Pitavastatin decreases serum LOX-1 ligand levels and MT1-MMP expression in CD14-positive mononuclear cells in hypercholesterolemic patients.
        Int J Cardiol. 2014; 176: 1230-1232
        • Sawamura T.
        • Wakabayashi I.
        • Okamura T.
        LOX-1 in atherosclerotic disease.
        Clin Chim Acta. 2015; 440: 157-163
        • Kobayashi N.
        • Takano M.
        • Hata N.
        • et al.
        Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a valuable diagnostic marker for rupture of thin-cap fibroatheroma: verification by optical coherence tomography.
        Int J Cardiol. 2013; 168: 3217-3223
        • Inoue N.
        • Okamura T.
        • Kokubo Y.
        • et al.
        LOX index, a novel predictive biochemical marker for coronary heart disease and stroke.
        Clin Chem. 2010; 56: 550-558
        • Sugiyama D.
        • Higashiyama A.
        • Wakabayashi I.
        • et al.
        The relationship between lectin-like oxidized low-density lipoprotein receptor-1 ligands containing apolipoprotein B and the cardio-ankle vascular index in healthy community inhabitants: the KOBE Study.
        J Atheroscler Thromb. 2015; 22: 499-508
        • Lorenz M.W.
        • Polak J.F.
        • Kavousi M.
        • et al.
        Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data.
        Lancet. 2012; 379: 2053-2062
        • Liviakis L.
        • Pogue B.
        • Paramsothy P.
        • Bourne A.
        • Gill E.A.
        Carotid intima-media thickness for the practicing lipidologist.
        J Clin Lipidol. 2010; 4: 24-35
        • Bentzon J.F.
        • Otsuka F.
        • Virmani R.
        • Falk E.
        Mechanisms of plaque formation and rupture.
        Circ Res. 2014; 114: 1852-1866
        • Lubrano V.
        • Cocci F.
        • Battaglia D.
        • Papa A.
        • Marraccini P.
        • Zucchelli G.C.
        Usefulness of high-sensitivity IL-6 measurement for clinical characterization of patients with coronary artery disease.
        J Clin Lab Anal. 2005; 19: 110-114